Area of research
Virology · Psychiatry and Mental health
Research interest
Research interests include HIV Research and Treatment, Schizophrenia research and treatment, Tryptophan and brain disorders, and Neuroinflammation and Neurodegeneration Mechanisms.
Reduced Brain Iron and Striatal Hyperdopaminergia in Schizophrenia: A Quantitative Susceptibility Mapping MRI and PET Study
Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN)
The role of low subcortical iron, white matter myelin, and oligodendrocytes in schizophrenia: a quantitative susceptibility mapping and diffusion tensor imaging study
695. IRON DYSHOMEOSTASIS IS LINKED TO DOWNREGULATED AMYLOID PRECURSOR PROTEIN IN SCHIZOPHRENIA PREFRONTAL CORTEX: A POSTMORTEM STUDY
Mesostriatal Dopaminergic Circuit Dysfunction in Schizophrenia: A Multimodal Neuromelanin-Sensitive Magnetic Resonance Imaging and [18F]-DOPA Positron Emission Tomography Study
Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders
Perturbed iron biology in the prefrontal cortex of people with schizophrenia
Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis
Clinical, Brain, and Multilevel Clustering in Early Psychosis and Affective Stages
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders
Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia
Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives
Invited Review: The spectrum of neuropathology in COVID‐19
The ubiquitin proteasome system and schizophrenia
Brain network dynamics in schizophrenia: Reduced dynamism of the default mode network
Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity
Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia
Exploring Heterogeneity on the Wisconsin Card Sorting Test in Schizophrenia Spectrum Disorders: A Cluster Analytical Investigation
Interrogating the Evolutionary Paradox of Schizophrenia: A Novel Framework and Evidence Supporting Recent Negative Selection of Schizophrenia Risk Alleles
Depression, fatigue and neurocognitive deficits in chronic hepatitis C
Insula Functional Connectivity in Schizophrenia: Subregions, Gradients, and Symptoms
Investigation of peripheral complement factors across stages of psychosis
Graphene foam as a biocompatible scaffold for culturing human neurons
PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia
Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia
No preliminary evidence of differences in astrocyte density within the white matter of the dorsolateral prefrontal cortex in autism
High heterogeneity and low reliability in the diagnosis of major depression will impair the development of new drugs
Abnormal microglial–neuronal spatial organization in the dorsolateral prefrontal cortex in autism
A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia